BioCentury
ARTICLE | Company News

Biorelease, TheraMed Partners deal

February 18, 1997 8:00 AM UTC

BREL terminated its proposed acquisition of TheraMed Partners, citing cost issues (see BioCentury Oct. 14). BREL also suspended its plan to spin out its Biorelease Technologies Inc. subsidiary, which...